Ads
-
Related paper
- FOLLOW-UP OF PATIENTS AND PROGNOSTIC IMPACT OF TUMOUR MARKER CA 15-3 ON PATIENTS OF BREAST CANCER: A RETROSPECTIVE COHORT STUDY
- Low PD-1 expression and no prognostic impact in early-stage Mycosis Fungoides: 61 patients retrospective cohort analysis
- Retrospective Study of a Cohort of Tunisian Patients with Thyroid Cancer
- A Prognostic Study of MDA, Sod and Catalase in Breast Cancer Patients
- Real World Evidence: Treatment of Patients with NonMetastatic Colon Cancer in a Community Hospital in Argentina: A Retrospective Cohort Study
- LOCOREGIONAL RECURRENCE IN PATIENTS WITH NODE NEGATIVE EARLY BREAST CANCER WHO RECEIVED ADJUVANT HYPOFRACTIONATED RADIOTHERAPY REGIMEN VS. CONVENTIONAL FRACTIONATION REGIMEN AFTER BREAST CONSERVATIVE SURGERY RETROSPECTIVE STUDY
- PROGNOSTIC SIGNIFICANCE OF COMPLETE BLOOD COUNT IN BREAST CANCER PATIENTS
- A RETROSPECTIVE OBSERVATIONAL STUDY ON RECEPTOR STATUS AND CO- MORBIDITIES OR HISTORY OF THYROID DISORDERS AND/OR GALLBLADDER STONES ASSOCIATED WITH BREAST CANCER PATIENTS
- Leukemoid reaction as a “prognostic marker” in breast cancer and review of literature
- Role of Serum Carcinoembryonic Antigen (CEA) as a Predictive and Prognostic Marker of Response to Treatment in Patients with Advanced Non Small Cell Lung Cancer (NSCLC)